Page 125 - 80_03

Cannabinoides…

59.
Alexander,
A.;
Smith,
P.
F.;
Rosengren,
R.
J.
Cannabinoids
in
the
treatment
of
cancer.
Cancer

Lett,
285
(1),
6-­-12
(2009).

60.
Engels,
F.
K.;
De
Jong,
F.
A.;
Mathijssen,
R.
H.;
Erkens
J.
A.;
Herings,
R.
M.;
Verweij,
J.

Medicinal
cannabis
in
oncology.
Eur
J
Cancer,
43
(18),
2638-­-2644
(2007).

61.
Brown,
I.;
Cascio,
M.
G.;
Rotondo,
D.;
Pertwee,
R.
G.;
Heys,
S.
D.;
Wahle,
K.
W.
Cannabinoids

and
omega-­-3/6
endocannabinoids
as
cell
death
and
anticancer
modulators.
Prog
Lipid

Res,
52
(1),
80-­-109
(2013).

62.
Baker,
D.;
Pryce,
G.;
Giovannoni,
G.
Thompson,
A.
J.
The
therapeutic
potential
of
cannabis.

Lancet
Neurol,
2
(5):291-­-298
(2003).

63.
Di
Marzo,
V.;
Piscitelli,
F.;
Mechoulam,
R.
Cannabinoids
and
endocannabinoids
in
metabolic

disorders
with
focus
on
diabetes.
Handb
Exp
Pharmacol,
(203),
75-­-104
(2011).

64.
Horváth,
B.;
Mukhopadhyay,
P.;
Haskó,
G.;
Pacher,
P.The
endocannabinoid
system
and

plant-­-derived
cannabinoids
in
diabetes
and
diabetic
complications.
Am
J
Pathol.,
180
(2),

432-­-442
(2012).

65.
Pinar-­-Sueiro,
S.;
Rodríguez-­-Puertas,
R.;
Vecino,
E.
Aplicaciones
de
los
cannabinoides
en

glaucoma.
Arch
Soc
Esp
Oftalmol,
86
(1),
16-­-23
(2011).

66.
Tomida,
I.;
Pertwee,
R.
G.;
Azuara-­-Blanco,
A.
Cannabinoids
and
glaucoma.
Br
J
Ophthalmol,

88
(5),
708-­-713
(2004).

67.
Abboud,
R.
T.;
Sanders,
H.
D.
Effect
of
oral
administration
of
delta-­-tetrahydrocannabinol
on

airway
mechanics
in
normal
and
asthmatic
subjects.
Chest,
70
(4),
480-­-485
(1976).

68.
Guimarães,
F.
S.;
Chiaretti,
T.
M.;
Graeff,
F.
G.;
Zuardi,
A.
W.
Antianxiety
effect
of
cannabidiol

in
the
elevated
plus-­-maze.
Psychopharmacology,
100
(4),
558-­-559
(1990).

69.
Guimarães,
F.
S.;
De
Aguiar,
J.
C.;
Mechoulam,
R.;
Breuer,
A.
Anxiolytic
effect
of
cannabidiol

derivatives
in
the
elevated
plus-­-maze.
Gen
Pharmacol,
25
(1)
161-­-164
(1994).

70.
Hall,
W.
The
adverse
health
effects
of
cannabis
use:
What
are
they,
and
what
are
their

implications
for
policy?.
Int
J
Drug
Policy.,
20
(6),
458-­-466
(2009).

71.
Danovitch,
I.;
Gorelick,
D.
A.
State
of
the
art
treatments
for
cannabis
dependence.
Psychiatr

Clin
North
Am,
35
(2),
309-­-326
(2012).

72.
McPartland,
J.
M.;
Russo,
E.
B.
Cannabis
and
cannabis
extracts:
greater
than
the
sum
of
their

parts?.
J.
Cannabis
Ther.,
1,
(3-­-4),
103-­-132
(2001).

73.
Russo,
E.
B.;
McPartland,
J.
M.
Cannabis
is
more
than
simply
D9-­-tetrahydrocannabinol.

Psychopharmacology,
165
(4),
431–432
(2003).

74.
Hall,
W.;
Christie,
M.;
Currow,
D.
Cannabinoids
and
cancer:
causation,
remediation,

and
palliation.
Lancet
Oncol,
6
(1),
35-­-42
(2005).

577